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The recent application of genome-wide, single nucleotide polymorphism (SNP) microarrays to investigate DNA copy number
aberrations in cancer has provided unparalleled sensitivity for identifying genomic changes. In some instances the complexity
of these changes makes them difficult to interpret, particularly when tumour samples are contaminated with normal (stromal)
tissue. Current automated scoring algorithms require considerable manual data checking and correction, especially when
assessing uncultured tumour specimens. To address these limitations we have developed a visual tool to aid in the analysis of
DNA copy number data. Simulated DNA Copy Number (SiDCoN) is a spreadsheet-based application designed to simulate the
appearance of B-allele and logR plots for all known types of tumour DNA copy number changes, in the presence or absence of
stromal contamination. The system allows the user to determine the level of stromal contamination, as well as specify up to 3
different DNA copy number aberrations for up to 5000 data points (representing individual SNPs). This allows users great
flexibility to assess simple or complex DNA copy number combinations. We demonstrate how this utility can be used to
estimate the level of stromal contamination within tumour samples and its application in deciphering the complex
heterogeneous copy number changes we have observed in a series of tumours. We believe this tool will prove useful to others
working in the area, both as a training tool, and to aid in the interpretation of complex copy number changes.
Citation: Nancarrow DJ, Handoko HY, Stark MS, Whiteman DC, Hayward NK (2007) SiDCoN: A Tool to Aid Scoring of DNA Copy Number Changes in
SNP Chip Data. PLoS ONE 2(10): e1093. doi:10.1371/journal.pone.0001093
INTRODUCTION
Single nucleotide polymorphism (SNP) microarrays provide data
on both genotype and signal intensity, the combination of which
can be used to generate information on chromosomal segment
copy number. An increasing number of studies utilise whole-
genome high density SNP chips to generate DNA copy number
profiles for a variety of tumour types. Kits and software tools are
now commercially available for this purpose from a number of
suppliers. This emerging technology has distinct advantages over
previous karyotype-based comparative genome hybridization
(CGH) methods [1] and analytic methods are evolving rapidly.
When applying these SNP microarrays (SNP-aCGH) to cancer
research, the aim is to synthesize a comprehensive DNA copy
number profile which maps aberrations across the entire genome
within individual tumour samples.
There are several method papers devoted to the analysis of DNA
copy number using SNP array platforms [2–5] and dedicated
software functions are available in commercial applications. There
are two broad approaches to this work: 1) identifying statistically
significant genomic regions of change (e.g. Colella and coworkers
[2]);2)developing toolstoauto-analysethedatatogenerate genome-
wide, sample specific DNA copy number profiles.
The success of SNP-aCGH for mapping sample specific DNA
copy number changes stems from the ability to combine CGH and
loss of heterozygosity (LOH) studies in the same analysis. As is
often the case with new biotechnology, the analysis procedures lag
behind the experimental advancements in terms of simplicity and
flexibility. While commercially available software applications
provide analysis algorithms to identify significant regions of
change, we [6] have found this to be inadequate for generating
a whole-genome view of DNA copy number changes without
heavy manual interpretation.
In SNP-aCGH analyses the resulting genotype data consist of
intensity values for two channels corresponding to the fluorophors
associated with the A & B alleles (attached to specific oligos/beads).
Data can be plotted as raw A versus raw B intensity plots, however
several refined data presentation methods have proven more useful.
One of these, log 2 of the sample intensity to reference intensity ratio
(logR),providesacontinuousmeasureoftheCGHcomponentofthe
data. In this case, the signal intensity of each SNP in the target
sample is expressed as a ratio over that of the normal sample or
reference pool. Log 2 of this ratio provides an effective means to
curtail the range of outlying values. While the variability of
individual logR values is large, due to variances in PCR conditions
and primer sequences, modified algorithms such as that of Nannya
and coworkers [7] and the Illumina proprietary method, as well as
the application of a moving average, are available to reduce the
effects of this variation across a chromosomal region. These features,
including a proprietaryalgorithm for SNP normalisation, arebuilt in
to the Illumina Beadstudio 2&3 software packages.
Another key SNP-aCGH data presentation track, Allele B
frequency (Ballele), visualises the LOH component. By adjusting
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in a panel of normal samples) the relative composition of each SNP
allele can be determined [4]. The Allele B frequency represents the
proportion contributed by one SNP allele (B), expressed as a range
from 0 to 1. Thus in a normal heterozygous sample (with equal
amounts of allele A and allele B for a given SNP) Ballele would be
0.5. Homozygosity is represented by either 0 (AA) or 1 (BB).
As with traditional LOH analysis by microsatellite or SNP
markers, a run of consecutive homozygous markers indicates
a region of potential DNA loss or copy neutral LOH. Intermediate
values (.0&,0.5 or .0.5 & ,1) represent variation in the
amount of allele B relative to the total (A+B) SNP intensity. This
can be seen, for example, as a result of incomplete loss of one
allele. Ballele plots tend to be less variable than those of logR [4].
The methods for calculating both Ballele and logR are described
in detail by Peiffer and coworkers [4].
When considered together, Ballele and logR plots of SNP-
aCGH data allow the relative amounts of each parental marker to
be estimated across each chromosome. It is unnecessary to type
parents for SNP-aCGH, thus the maternal or paternal origin of an
individual chromosome is unknown. However, as one delves into
deeper levels of DNA copy number complexity there is a need to
be able to clearly express which genotype is being referred to. As
an example, a 3n genotype (simple amplification) can consist of
chromosome segments from the same parent (AAA)o ra n
imbalance of chromosomes from both parents (AAB, ABB). SNP-
aCGH can distinguish AAA from the other two forms of 3n
amplification (which would require parental information to be
separated), and there may be a biological distinction; does a target
gene within an AAA region function in the context of tumour
suppression, or as an oncogene? In this manuscript we have
designated A and B to distinguish between paired chromosomes to
allow a more detailed description of the observable genotypes.
Note that italics have been used to distinguish A & B parental
chromosomes from the A and B alleles at an individual SNP. We
chose this nomenclature since ‘‘A’’ and ‘‘B’’ have historically been
used extensively in both instances.
Interpreting Ballele and logR plots together provides an
estimate of the average copy number of A and B versions of each
autosome, thus providing a sample specific genome-wide profile of
DNA copy number. These views essentially correspond to data
generated from the original CGH (,logR) and LOH (,Ballele)
methodologies and it is the ability to simultaneously interpret both
in a very dense map that makes SNP-aCGH so powerful.
When compared to cancer cell lines, DNA from a tumour
biopsy often generates a distinctively different pattern (Ballele &
logR) for a variety of the common copy number changes observed
when using SNP microarrays. This is due to the presence of non-
cancer cells within the biopsy, including inflammatory cells,
connective tissues and other components referred to as stromal
contamination (normal 2n chromosomal complement). Even
a small amount of non-cancer tissue (5–10%) will substantially
alter the appearance of logR and Ballele plots of certain changes,
such as LOH and homozygously deleted (HD) regions (discussed
in detail below). Since the proprietary algorithms have been
developed and optimized for use with cell lines they perform
poorly for tumour biopsies contaminated with stromal tissue.
Several problems arise when attempting to provide a detailed
genome-wide profile, particularly in tumour biopsies, all of which
can be related to the ability to interpret the critical data captured
within the Ballele and logR plots, whether manually, or by some
algorithm. Here we describe a simple application which simulates
all possible DNA copy number changes in terms of Ballele and
logR plots. We believe this tool, Simulated DNA Copy Number
(SiDCoN), will be helpful for interpreting complex regions of
change, as well as for training researchers to accurately score
whole-genome profiles in the presence of significant stromal
contamination. Furthermore SiDCoN allows the user to estimate
the level of stromal contamination within a tumour sample.
RESULTS AND DISCUSSION
SiDCoN was used to generate simulated data for all common
DNA copy number changes, assuming either no stromal
component to the sample, such as seen for a tumour cell line
(Figure 1a), or assuming a 20% stromal component, as might be
expected for an average tumour biopsy (Figure 1b). The following
sections describe the defining features of each DNA copy number
variation presented in Figure 1, highlighting the effect the presence
of stroma has on the profiles.
Observable DNA Copy Number Genotypes
Normal [2n, AB] Since stroma is assumed to be normal 2n
chromosomal complement, Ballele and logR plots are identical for
tumour cell lines (Figure 1a) and tumour biopsies (Figure 1b). The
B allele frequencies for each SNP are either close to zero (no B
allele) or 1 (2 B alleles) indicating uninformativeness, or close to 0.5
indicating a heterozygous signal with equal proportions of both
alleles. Deviations from 0.5 are the result of ‘‘random’’ fluctuations
in the experimental system. Across a chromosomal region
(multiple SNPs) the relative B-allele intensity sits around 0.5 and
the logR is expected to be close to zero; equal proportions of
sample and reference DNA resulting in a ratio of 1 and a log2
value of zero. When scoring a region as normal 2n, with a B-allele
at 0.5, it is important that the logR be at zero since there are
several alterations which have a normal B allele (see HD and 4n
normal below). This is one of the major benefits of using a matched
normal sample as a reference, rather than the Illumina reference
cluster, as described by Peiffer and coworkers [4].
Loss of Heterozygosity (LOH) [1n, A or B] LOH is one of
the most common DNA copy number changes seen in cancer and
its occurrence can help localize the position of a tumour
suppressor gene. As can be seen from Figure 1 the presence of
stromal tissue changes the appearance of the Ballele plot. When
the sample contains 100% tumour cells, all with LOH in the
region of study, the Ballele plot consists of values either close to
zero or close to 1, since there is only one allele present in the
sample (Figure 1a). We can label this as pure LOH. However,
when stromal tissue is present the allele B frequency for each
polymorphic SNP shifts towards 0.5 (Figure 1b). The extent of the
shift can be directly proportional to the level of stroma and this
phenomenon is described in detail under ‘‘Estimating Stromal
Contamination’’ (Figure 2a). Pure LOH results in an expected
logR value of minus 0.54 (Illumina Beadstudio manual) as shown
in Figure 1a, and, as can be seen in Figure 2a, the presence of
stroma makes this signal weaker (closer to zero) in a proportional
manner.
Copy Neutral LOH (N-LOH) [2n, AA or BB] N-LOH, or
uniparental disomy, is actually the result of two events, first LOH
occurs, removing one copy of the target chromosomal region and
then this region is duplicated. Alternatively amplification followed
by loss of the non-amplified chromosome can result in N-LOH.
The resulting genotype is a normal (2n) DNA complement which
consists of the same chromosomal version: AA or BB instead of the
AB seen in a normal heterozygous region. One of the advantages
of using a SNP platform to document DNA copy number changes
in tumours is that, unlike karyotype-based CGH methods, N-LOH
can be distinguished from normal 2n [1]. With standard LOH
SiDCoN
PLoS ONE | www.plosone.org 2 October 2007 | Issue 10 | e1093Figure 2. Simulated Ballele (top) and logR (bottom) plots showing serial dilution of the a) loss of heterozygousity, and b) amplification (3n)
tumour genotypes in the presence of increasing levels of stromal (normal). In each case stromal levels of 0% (pure tumour) to 80% are represented
in steps of 10% (separated by vertical lines), along with the normal 2n genotype.
doi:10.1371/journal.pone.0001093.g002
Figure 1. A comparison of DNA copy number genotypes showing Ballele (top) and logR (bottom) simulated data for a) tumour cell line showing
100% changes in each case, and b) tumour biopsy with 80% tumour and 20% stromal (normal) DNA. In each case all common DNA copy number
changes are represented (separated by vertical lines) and discussed sequentially within the text.
doi:10.1371/journal.pone.0001093.g001
SiDCoN
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characterization of N-LOH events is relatively new. N-LOH is
surprisingly common in a variety of tumours [1]. As with pure
LOH, pure N-LOH results in a Ballele plot that consists of values
close to zero or 1, since all the SNPs are homozygous (Figure 1a).
When stromal tissue is present the Ballele plot does shift towards
0.5 as seen with LOH, however the degree of this shift is different,
but predictable (Figure 1b). The N-LOH genotype results in a logR
value that is close to zero (the same as normal 2n tissue) in either
the presence or absence of stroma (Figure 1).
Amplified LOH (AMP-LOH) [3n, AAA or BBB] The
formation of AMP-LOH is similar to that of N-LOH, except
that the chromosomal region resulting from LOH is duplicated
more than once. Figure 1 only depicts AAA amplification (3n),
although it is possible to use SiDCoN to simulate as many n as
required. As with both LOH and N-LOH, pure AMP-LOH will
present a B-allele plot consisting of 0 or 1 values (with the system
variation) irrespective of how many times the region has been
duplicated, and the logR value will approximate that of 3n
amplification (,0.34 – Illumina Beadstudio manual) if there are 3
versions of the target chromosomal region, AAA (Figure 1a). When
stromal tissue is present the Ballele plot shifts towards 0.5, and
again, the degree of shift relates to the amount of normal tissue
present (Figure 1b). The level of stromal contamination also
controls the strength of the gain observed in the logR. Given the
small shift (0.34) expected for pure 3n genotypes, increasing levels
of stroma make the logR signal closer and closer to zero. With the
degree of variation within the logR signal it is often difficult to
distinguish AMP-LOH from N-LOH in the presence of more than
60% stroma.
Homozygous Deletion [0n, 0] The most apparent change
associated with a pure homozygous deletion (HD) in cell lines is
a very low logR score, below 22 and often dipping below 24. In
the presence of stroma, however, the magnitude of the change can
be substantially smaller, depending upon the amount of non-
cancer tissue present. In the case of complete HD within a cell line,
where essentially no DNA remains for the chromosomal region in
question, there is not enough signal for an accurate determination
of the allele B frequency of each SNP, resulting in essentially
random numbers for the Ballele plot (Figure 1a). In the presence of
even a trace of non-cancer cells there is sufficient material to gain
an accurate allele B frequency, however, since this arises solely
from non-cancer tissue the Ballele plot appears as normal 2n.
Therefore, unlike pure HD, HD in the presence of stroma can
only be distinguished from normal 2n by the drop in logR
(Figure 1b). It should be noted that in tumours HD is often mixed
with LOH, as discussed below.
When scoring HD on the X chromosome of male subjects, it
should be remembered that the normal state (one X chromosome)
has a 1 or 0 Ballele pattern. Thus the loss of the remaining allele is
only evident by the drop in logR value. The difference between
HD in the presence or absence of non-cancer cells is only
evidenced by the degree of logR drop (data not shown).
4n Balanced Amplification [4n, AABB] When the normal
chromosomal complement (2n) is duplicated within the target
region the logR plot is representative of 4n, while the Ballele plot
shows a normal 0.5 signal (Figure 1). In the case where there is
a mixture of normal stroma and target-specific tetraploid cells, the
strength of the logR signal increase is reduced, while the B allele is
unchanged (Figure 1b vs Figure 1a). If a proportion of the tumour
sample is tetraploid (4n total chromosome complement), which
often happens in a number of cancer types, this is not detectable
by current SNP-aCGH analyses, due to the necessity to normalize
DNA content between sample and reference.
Simple Amplification (3nAMP) [3n, AAB or ABB] In
combination with LOH, regions of genomic amplification are
considered hallmarks of the tumour genotype. While LOH often
denotes the presence of a tumour suppressor, amplification is
indicative of gene(s) that have an oncogenic effect. Given the small
shift of 0.34 expected for pure 3n amplified genotypes (Figure 1a),
the presence of a moderate proportion of stroma shifts the logR
signal close to zero (Figure 1b), such that it is often difficult to
distinguish 3n from 2n using logR alone (Figure 2b). In pure
3nAMP the Ballele plot has a characteristic split, with clusterings
at 0.66 and 0.34 amongst polymorphic SNPs (along with
nonpolymorphic SNPs which cluster at either 1 or 0), indicating
that either 2/3 or 1/3 of the alleles are B at individual SNPs
(Figure 1a). Consistent with the other changes described above, the
presence of stroma shifts the Ballele signal back towards 0.5. The
degree of shift is proportional to the percentage of cells with
a normal genotype, as shown in Figure 2b. Note the distinctions in
Ballele plot between 3nAMP (AAB) and AMP-LOH (AAA) making
it possible to clearly distinguish these two genotypes, even in the
presence of stroma (Figure 1).
Complex Amplification [e.g. 4n, AAAB] Higher levels of
amplification are reasonably common in tumour samples, e.g.
around oncogenes such as ERBB2 and MYC. They differ from
3nAMP in the degree of shift towards 1 in the Ballele plot and
increasing logR values, as the ratio of amplified to normal alleles
increases in relation to the total number of DNA copies. As the
number of copies increases, the possible number of genotype
combinations also grows, although generally one allele is chosen to
be overrepresented. Figure 1 illustrates 4nAMP (AAAB), 5nAMP
(AAAAB) and 6nAMP (AAAAB). Note the clear distinction in B
allele plot for 4nAMP (AAAB) and 4n-ploidy (AABB) in Figure 1. In
the presence of stroma it becomes very difficult to unambiguously
distinguish 3nAMP from 4nAMP unless the degree of stromal
contamination is known (data not shown). Using SiDCoN one can
demonstrate that the allelic mixtures for higher levels of
amplification (.6n) are difficult to distinguish, especially in the
presence of stroma (data now shown).
Esimating Stromal Contamination in Tumour
Samples
Cancer researchers often only have access to small biopsies of
tumours, from which accurate estimates of stromal contamination
can be difficult. Visual estimates based on the histologic
appearance of a neighbouring tissue section can be used as
a guide, but there is no guarantee that the section is representative.
If the biopsy is small, halving it for pathology considerably reduces
yield (often disproportionately) and the tumour content estimate is
still only a guide. For both expression and DNA copy-number
profiling the presence of large amounts of stromal tissue will
reduce the number of differences observed; introducing a type 2
error.
As can be seen in Figure 2, the amount of non-cancer tissue
present within a tumour alters both the B allele and logR signals
for several copy number changes. We propose that at the site of
any of the simple copy number changes seen in tumours (LOH, N-
LOH & 3nAMP) the degree of shift can be used to estimate the
percentage of cells that have a normal 2n genotype. Using
SiDCoN we have been able to assess the tumour/normal DNA
mixing experiment presented in Figure 5 (plates A-E) of Peiffer et
al [4]. By simulating various ratios of normal and LOH genotypes
it is possible to estimate the tumour DNA content in each of the
75%, 50% and 25% mixtures generated by Peifer and coworkers
as approximately 71%, 45% and 22% respectively, based on the
SiDCoN
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5, plate F of Peiffer et al [4] can also be estimated from the LOH
stretch present across the later half of chromosome 13. We
estimate that the 0.67 Ballele split corresponds to 52% tumour (or
,50% from the serial dilution presented in Figure 2a), rather than
67% as described in their legend to figure 5 [4]. Peiffer and
coworkers have not accounted for the fact that the LOH genotype
contains only one chromosome (A), while the normal 2n (stromal)
component contains both A and B chromosomes. Thus, the
calculation actually is 2 – (1/0.67), rather than 0.67/1, as they
assume. We thought it important to highlight this point since this is
the only other published example of applying Ballele and logR
plots to estimating stromal contamination level.
Figure 3 demonstrates the use of SiDCoN (Figure 3b) to
determine the region-specific level of involvement in a specific
DNA sample (Figure 3a). In this example, the sample shows 40%
normal cells for both the indicated 3nAMP (p arm) and LOH (q
arm), based on the visual similarity of these profiles to that of the
actual data; particularly the Ballele plot. Using this visual
approach, the level of cellular involvement can be estimated for
each DNA copy number change present in a sample.
Furthermore, when multiple DNA copy number changes are
present in a sample it is possible to estimate the degree of stromal
contamination present in a given tumour biopsy, with the aid of
SiDCoN. There are two major complications to this procedure:
1) Multiple regions of DNA copy number change are
required At any given region of the genome a tumour might be
heterogeneous for a DNA copy number change, such that
a proportion of the tumour cells show a change and the
remainder are normal or show a different DNA copy number
change. Thus, estimating the stromal contamination rate from
a single DNA copy number change may be inaccurate. In
addition, across a given chromosome, the pattern of DNA copy
number change is likely to vary. One must be certain to choose
consistent regions of change. For example across a given
chromosome arm the level of LOH may vary. The region of
LOH which is closest to the Ballele plot expected for pure LOH
(Figure 1a) is most likely to give an accurate estimation of the
percentage of stroma present. Note that the X chromosome should
be excluded from this estimation in samples of male origin.
2) Scoring ambiguity As discussed above, at higher levels of
stromal contamination it becomes difficult to clearly determine the
specific tumour genotype in a given region. Estimating the level of
stroma from LOH is the most accurate, simply because the Ballele
pattern is the most different from normal. Experimentally we find
we can score LOH down to 30% of the sample (Figure 2a),
however this is dependent on the ability to discriminate LOH from
N-LOH on the logR plot, and thus a straight baseline is required.
Taking these factors into consideration, when a primary tumour
sample exhibits a number of unambiguous LOH changes across
Figure 3. Estimating AMP & LOH levels in a) real data using b) SiDCoN. Comparison to simulated data indicates that ,60% of cells are AMP or LOH
for the indicated regions (thus 40% of cells are normal 2n in each case). These data suggest that this tumour biopsy contains 40% stroma, although
more copy number changes across the genome are needed to confirm this.
doi:10.1371/journal.pone.0001093.g003
SiDCoN
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the level of contaminating normal stromal material, as shown from
the set of simulations provided in Figure 2 where LOH and AMP
changes are provided in 10% steps. Practically, we limit our serial
steps to 5% when using SiDCoN in this manner, although either 5
or 10% steps provide a good estimate, depending on the number
of scorable changes per sample (down to 30% as described above).
While the amount of stromal contamination does effect how
much the logR mean value does shift towards zero, it is not as
accurate as using the Allele B frequency for estimating the stromal
contamination level.
Investigating region-specific DNA copy number
heterogeneity in tumour samples
Figure 4 demonstrates the application of SiDCoN to interpreting
the level of DNA copy number change in the presence of stroma
(4b and 4c), and estimating the mixture levels of multiple copy
number changes (4a and 4b). At the beginning of the melanoma
cell line chromosome excerpt depicted in Figure 4a (top) is a region
consisting of a combination of LOH and HD cells. Using the
simulator (4a bottom) it can be estimated from the logR values that
this is the result of 70% of the cell line population being LOH for
this region, while the remaining 30% are homozygously deleted.
This is consistent with the fact that within this region of 70%
LOH/30% HD, is a 100% HD region which contains a known
melanoma tumour suppressor gene (CDKN2A). Similarly, in
Figure 4b (top) the central section of the chromosomal excerpt
from an oesophageal adenocarcinoma tumour biopsy shows
a region with a mixture of LOH and HD tumour cells, however
in this case normal 2n (stromal) cell population is also present.
Note that, at the beginning of this excerpt there is a region of LOH
alone, in the presence of a normal 2n population. Using the
simulator in the manner demonstrated in Figure 3 we estimate that
in each case the normal 2n population is ,25% and that the 75%
LOH region moves to a mixture of 50% LOH and 25% HD
within the central region of the section shown (Figure 4b). By
looking at LOH regions across all autosomes for this sample, we
confirmed that the stromal contamination rate within the biopsy
sample is ,25% (data not shown) suggesting that all tumour cells
are involved in the changes described.
As the application of SNP-aCGH to investigate DNA copy
number changes becomes more popular, investigators will want to
extract as much information as possible from these data. We
present here a simple simulation-based method to investigate
complex DNA copy number changes to a level beyond current
analytical methods. While the application of our method is
manual, in relation to users adjusting the simulated parameters to
obtain a visual match for individual data, SiDCoN provides
researchers with the flexibility to assess a wide variety of SNP-
Figure 4. Some examples of observed vs simulated chromosomal excerpts showing mixed populations of DNA copy number changes (top) and
the manually adjusted simulations of these changes (bottom). a) a melanoma cell line with changes including HD and mix of LOH & HD. b) an EAC
tumour biopsy profile which includes LOH, N-LOH and a mix of HD and LOH. The simulator is particularly useful for explaining LOH/HD combinations
in the presence of stroma as seen here. c) another EAC tumour biopsy with changes on a higher background of stroma/normal cells. Manually
adjusting the simulator is useful for determining the level of tumour cell involvement in each change.
doi:10.1371/journal.pone.0001093.g004
SiDCoN
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approach can be used to estimate the stromal contamination rate
within tumour biopsies, and to describe mixed DNA copy number
populations, in the presence or absence of normal 2n cell
populations. There is also the potential to implement the basic
principles of our application into next-generation autoscoring
programs which may save researchers considerable time.
METHODS
Test samples
DNA was extracted from melanoma cell lines and oesophageal
adenocarcinoma biopsies using Qiagen nucleic acid column
purification technology as set out in the manufacturer’s instruc-
tions (Qiagen, Hilden, Germany). The resulting genomic DNA
was quantitated using a Nanodrop and 750ug applied to Infinium
II Whole Genome Genotyping HumanHap300 Beadarray chips
as per manufacturer’s instructions (Illumina, San Diego, CA,
USA). The chip image data was then processed through
Beadstation and Beadstudio 2 software applications to generate
B-allele and logR plots. In the case of melanoma cell lines, the
Illumina reference pool was used as a reference. For the
adenocarcinoma biopsies a normal squamous oesophageal biopsy
(from one of the cancer patients) was used as a reference. The
normal squamous tissue was compared to the Illumina reference
pool to look for any anomalous regions. This highlighted a small
region of change on 6q which was excluded from the analyses of
the oesophageal tumour biopsies. We found, as reported by Peiffer
and co-workers [4], that using a local normal tissue in this manner
gave a much cleaner baseline signal compared to using the
Illumina pooled reference.
Using SiDCoN
SiDCoN (Supplement S1) is an Microsoft EXCEL spreadsheet
application that allows users to enter up to 3 copy number
genotypes, along with a stromal proportion, for up to 5000
observable datapoints (SNPs). Supplement S2 is a help file
outlining its usage. Generally, we envisage its use will be restricted
to estimating one genotype and stromal contamination, or
a mixture of 2 copy number variants; however we wanted the
tool to be as flexible as possible. Each copy number genotype is
entered into the main ‘‘datasheet’’, along with the proportion of
cells (0–1) with this type (Figure 5a). If the total of the 3 genotypes
for a SNP is less than 1, the remaining portion is assumed to be
stroma (normal 2n, AB). The relative proportion each entered
DNA copy number genotype makes towards the overall pattern is
determined using predetermined values from the ‘‘lookup’’ sheet,
shown in Figure 5b, and the entered fractions. From these
calculations the expected Ballele and logR values are determined
for each SNP (columns V and W on the right hand side of
Figure 5a). A randomization algorithm is then applied to each
datapoint, using the EXCEL ‘‘RAND()’’ function, to allow the
simulated data plots to appear visually similar to real data. The
resulting Ballele and logR plots are then presented as EXCEL
graphs on separate sheets (not shown), or combined on the ‘‘both
graphs’’ sheet (Figure 5c). The results (Figure 1) provide a means
to generate reasonable facsimiles of actual DNA copy number
Figure 5. Screen grabs from SiDCoN showing a) the main ‘‘datasheet’’ interface with space for three DNA copy number genotypes and a stromal
component for each SNP, b) the lookup sheet containing information needed for calculations dependent on the copy number genotypes
entered and c) the Ballele and logR output, implementing randomised values to visually simulate the look of actual data.
doi:10.1371/journal.pone.0001093.g005
SiDCoN
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observed in the real data.
Ballele frequency graphs focus around 3 (normal 2n) or 4 lines
which correspond to whether the B allele for each SNP is
informative or uninformative with either no copies (0) or all copies
(1) of allele B. When the B allele is informative it can either be the
predominant SNP allele (.0.5), the minimal SNP allele (,0.5) or
in equal proportion with A (0.5). The latter case, results in 3 focus
lines (1, 0.5 & 0) (see Figure 1a, normal & 4-ploid). Instances where
there is only 1 parental chromosome present result in only 2 lines
of focus (0 & 1) (see Figure 1a, LOH, N-LOH and AMP-LOH)
while all other instances result in 4 lines of focus. Since all SNPs in
the current assay have only two possible alleles (A & B) this is
always the case (even for sex chromosomes), unless there are more
than 2 parental chromosomes present. To be consistent with
Peiffer and coworkers [4], we represent Ballele as the position of
the upper informative line of focus, giving a range of 0.5 to 1. A
value of 1 means only one parental chromosome is present such
that no SNPs are informative (lines of focus at 0 and 1) as is the
case for complete LOH. A value of 0.5 indicates a normal (2n)
Ballele appearance with lines of focus at 1, 0 and 0.5, while other
values (between 1 and 0.5 indicate there are 4 lines of focus 1, 0,
Ballele and 1-Ballele).
SiDCoN generates simulated mean logR values using the
formula:
*mean logR ~ Log(sum of all genotype proportions=2)  2
We expected that log2 would yield the correct result, but for some
reason log10, in the simulations, provides much closer values to
observed logR values. Presumably this is the result of using
simulated R values.
SUPPORTING INFORMATION
Supplement S1 Simulated DNA Copy Number (SiDCoN) -
a spreadsheet application designed to simulate the appearance of
B-allele and logR plots for all known types of tumour DNA copy
number changes in the presence or absence of stromal
contamination
Found at: doi:10.1371/journal.pone.0001093.s001 (4.89 MB
XLS)
Supplement S2 Instructions for using SiDCoN
Found at: doi:10.1371/journal.pone.0001093.s002 (0.03 MB
DOC)
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